Free Trial
→ Why More Investors Are Using Family Trusts to Protect Their Wealth (From SmartAsset) (Ad)tc pixel

Novozymes A/S (OTCMKTS:NVZMY) Stock Rating Lowered by Zacks Research

Written by MarketBeat
Updated September 1, 2025
Novozymes A/S logo with Basic Materials background

Key Points

  • Novozymes A/S has been downgraded from a "strong-buy" rating to a "hold" rating by Zacks Research, reflecting a more cautious outlook for the company.
  • The company's stock opened at $62.57 and has a market capitalization of $29.30 billion, indicating its significance in the industrial enzymes market.
  • Novozymes A/S specializes in producing industrial enzymes and probiotics for various sectors, including the food and beverage industry and hygiene products.
  • MarketBeat previews the top five stocks to own by October 1st.

Zacks Research lowered shares of Novozymes A/S (OTCMKTS:NVZMY - Free Report) from a strong-buy rating to a hold rating in a research note issued to investors on Monday, August 25th,Zacks.com reports.

Novozymes A/S Stock Down 0.8%

Shares of NVZMY stock traded down $0.51 during trading hours on Monday, reaching $64.20. The company had a trading volume of 59,096 shares, compared to its average volume of 49,861. The company has a debt-to-equity ratio of 0.11, a quick ratio of 1.04 and a current ratio of 1.66. Novozymes A/S has a twelve month low of $53.95 and a twelve month high of $75.99. The company has a market capitalization of $30.06 billion, a P/E ratio of 40.63, a price-to-earnings-growth ratio of 1.26 and a beta of 0.93. The stock's fifty day simple moving average is $67.90 and its 200 day simple moving average is $65.32.

Novozymes A/S Cuts Dividend

The firm also recently declared a dividend, which will be paid on Thursday, September 11th. Investors of record on Wednesday, September 3rd will be issued a $0.1856 dividend. The ex-dividend date of this dividend is Tuesday, September 2nd. This represents a yield of 88.0%. Novozymes A/S's dividend payout ratio is currently 48.10%.

Novozymes A/S Company Profile

(Get Free Report)

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.

See Also

Should You Invest $1,000 in Novozymes A/S Right Now?

Before you consider Novozymes A/S, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novozymes A/S wasn't on the list.

While Novozymes A/S currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Ride The A.I. Megaboom Cover
7 Stocks to Ride The A.I. Megaboom


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report
Like this article? Share it with a colleague.